JW Pharmaceutical Corporation (001067.KS) Debt-to-Equity Ratio
As of May 22, 2026
TL;DR — 001067.KS debt-to-equity is 0.15
JW Pharmaceutical Corporation (001067.KS) currently carries a debt-to-equity ratio of 0.15 (conservative). Interest coverage is N/A and the current ratio is 1.42. Very low leverage — the company is largely funded by equity, with plenty of room to take on debt if needed. Common for mature cash-cow businesses.
Current leverage profile
Debt / Equity
0.15
Total debt / shareholder equity
Interest coverage
N/A
EBIT / interest expense
Current ratio
1.42
Short-term liquidity
D/E in isolation is a starting point, not a verdict. To get a credible read on solvency you also want to see interest coverage above 3x (so EBIT comfortably pays interest) and a current ratio above 1.2 (so short-term assets cover short-term obligations). When those two are healthy, even a higher D/E is usually manageable.
5-Year debt-to-equity trend
Historical D/E series is not yet available for 001067.KS.
Industry comparison
Sector D/E median is not yet available for this ticker.
Interpreting 001067.KS's debt-to-equity
What "Conservative" means here: Very low leverage — the company is largely funded by equity, with plenty of room to take on debt if needed. Common for mature cash-cow businesses.
Sector context matters: a D/E of 1.5 in financials or utilities is normal. The same number in software or pharma is a yellow flag. Always anchor your read against the sector median above before forming a view.
Watch the direction: a slowly rising D/E is fine if return on invested capital (see the fundamentals page) is comfortably above the cost of debt. A rapidly rising D/E paired with deteriorating ROIC is the classic distressed-equity pattern.
Stress test: ask yourself what 001067.KS looks like if revenue drops 20% for two years. With its current interest coverage of N/A, can the company keep paying interest? The Altman Z-Score on the fundamentals page is a quick formal version of this question.
Related 001067.KS analyses
Frequently asked about 001067.KS debt-to-equity
What is 001067.KS's debt-to-equity ratio?↓
001067.KS's current debt-to-equity ratio is 0.15 as of May 22, 2026. That puts it in the "Conservative" category. Very low leverage — the company is largely funded by equity, with plenty of room to take on debt if needed. Common for mature cash-cow businesses.
How is debt-to-equity calculated?↓
Debt-to-equity = total debt / shareholders' equity. Total debt usually includes both short-term and long-term interest-bearing borrowings (sometimes called total liabilities in older definitions). We use the FMP "debtEquityRatioTTM" field, which is total debt over equity on a trailing twelve-month basis.
Is 001067.KS's D/E ratio safe?↓
"Safe" depends on the business model. A 0.15 D/E is conservative. The more important question is cash coverage: with an interest-coverage ratio of N/A and a current ratio of 1.42, 001067.KS can service its debt obligations at the current operating level.
How does 001067.KS compare to the sector average?↓
Sector debt benchmarks for this ticker are still being ingested.
When is high debt-to-equity dangerous?↓
High D/E is dangerous when (1) cash flow coverage is weak (interest coverage below 3x), (2) earnings are cyclical or capital-intensive, (3) refinancing exposure is concentrated in the next 12-24 months, (4) the company is paying out a large dividend or running buybacks while issuing more debt. Conversely, high D/E can be perfectly fine for stable-cash-flow utilities, REITs, and regulated financials — context matters.